Trulieve Cannabis (TCNNF) Other Non-Current Assets (2020 - 2026)
Trulieve Cannabis (TCNNF) recorded quarterly Other Non-Current Assets of $1.9 million in Q1 2026, up 122.0% quarter-over-quarter from $859000.0 in Q4 2025, and up 110.25% on a YoY basis from $907000.0 in Q1 2025.
Trulieve Cannabis (TCNNF) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Trulieve Cannabis' Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $1.9 million for Q1 2026.
- In Q1 2026, Other Non-Current Assets rose 110.25% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $1.9 million (up 110.25% YoY), while the FY2025 annual figure was $859000.0, down 95.31% from the prior year.
- Other Non-Current Assets was $1.9 million for Q1 2026 at Trulieve Cannabis, up from $859000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $18.3 million in Q4 2024 to a low of $859000.0 in Q4 2025.
- Historically, Other Non-Current Assets has averaged $6.4 million across 5 years, with a median of $6.6 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets surged 177.42% in 2024, then tumbled 95.31% in 2025.
- A 5-year view of Other Non-Current Assets shows it stood at $6.6 million in 2022, then changed by 0.0% to $6.6 million in 2023, then surged by 177.42% to $18.3 million in 2024, then sank by 95.31% to $859000.0 in 2025, then soared by 122.0% to $1.9 million in 2026.
- The last three Other Non-Current Assets figures came in at $1.9 million (Q1 2026), $859000.0 (Q4 2025), and $10.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.79 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 351.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 233.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 73.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 295.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 59.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 47.63 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Trulieve Cannabis | - | - | 170.08 Mn | 1.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.91 Mn |
| Dec 31, 2025 | 859,000.00 |
| Sep 30, 2025 | 10.42 Mn |
| Jun 30, 2025 | 1.95 Mn |
| Mar 31, 2025 | 907,000.00 |
| Dec 31, 2024 | 18.33 Mn |
| Jun 30, 2024 | 959,000.00 |
| Mar 31, 2024 | 2.01 Mn |
| Dec 31, 2023 | 6.61 Mn |
| Sep 30, 2023 | 11.09 Mn |
| Jun 30, 2023 | 7.58 Mn |
| Mar 31, 2023 | 7.15 Mn |
| Dec 31, 2022 | 6.61 Mn |
| Jun 30, 2022 | 9.70 Mn |
| Mar 31, 2022 | 9.50 Mn |
| Dec 31, 2021 | 3.01 Mn |
| Sep 30, 2021 | 12.08 Mn |
| Jun 30, 2021 | 13.79 Mn |
| Mar 31, 2021 | 11.24 Mn |
| Dec 31, 2020 | 7.53 Mn |